Trials / Completed
CompletedNCT05472376
Real-Life Study in Diabetic Macular Edema
Real-World Outcomes of Anti-VEGF Treatment for Diabetic Macular Edema in Turkey: A Multicenter Retrospective Study, MARMASIA Study Group
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 854 (actual)
- Sponsor
- Kocaeli University · Academic / Other
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
The goal of this study is to evaluate the real-world outcomes of intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment in diabetic macular edema (DME) patients.
Detailed description
The study included patients who were being observed in the retina departments of 8 tertiary hospitals in the Northern Marmara Region of Turkey (Istanbul's Asian Side, Kocaeli, and Sakarya). The records of DME patients treated with an anti-VEGF agent between January 2015 and December 2018 were reviewed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Retrospective study | Retrospective study |
Timeline
- Start date
- 2020-11-29
- Primary completion
- 2022-03-17
- Completion
- 2022-06-15
- First posted
- 2022-07-25
- Last updated
- 2022-07-25
Locations
10 sites across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05472376. Inclusion in this directory is not an endorsement.